Gerard Brophy - 02 Jan 2023 Form 4 Insider Report for Avantor, Inc. (AVTR)

Role
EVP, Biopharma Production
Signature
Scott Baker, as Attorney-in-Fact
Issuer symbol
AVTR
Transactions as of
02 Jan 2023
Transactions value $
-$141,872
Form type
4
Filing time
04 Jan 2023, 15:58:10 UTC
Previous filing
23 May 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTR Common Stock Tax liability -$141,872 -6,727 -6.94% $21.09 90,208 02 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.